↓ Skip to main content

PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient

Overview of attention for article published in CVIR Endovascular, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
27 Mendeley
Title
PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient
Published in
CVIR Endovascular, July 2019
DOI 10.1186/s42155-019-0067-z
Pubmed ID
Authors

Michiel A. Schreve, Michael Lichtenberg, Çagdas Ünlü, Daniela Branzan, Andrej Schmidt, Daniel A. F. van den Heuvel, Erwin Blessing, Marianne Brodmann, Vincent Cabane, William Tan Qing Lin, Steven Kum

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 19%
Researcher 3 11%
Student > Doctoral Student 2 7%
Student > Master 2 7%
Student > Ph. D. Student 1 4%
Other 2 7%
Unknown 12 44%
Readers by discipline Count As %
Medicine and Dentistry 6 22%
Nursing and Health Professions 5 19%
Computer Science 2 7%
Psychology 1 4%
Social Sciences 1 4%
Other 1 4%
Unknown 11 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2020.
All research outputs
#14,725,123
of 23,578,176 outputs
Outputs from CVIR Endovascular
#228
of 346 outputs
Outputs of similar age
#191,592
of 347,262 outputs
Outputs of similar age from CVIR Endovascular
#7
of 13 outputs
Altmetric has tracked 23,578,176 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 346 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,262 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.